Yongjie Wang (Yongie Wang)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Acute Myeloid Leukemia

Artificial Intelligence

Prognostic Factors

Top Venues

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yongjie Wang, Xiaolong Ma, Enjie Xu, Zhen Huang, Chen Yang, Kun-Peng Zhu, Yang Dong, Chun-Lin Zhang
Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index. Clinical and translational medicine 14 (2) (2024)
Yongjie Wang, Xiaolong Ma, Enjie Xu, Zhen Huang, Chen Yang, Kun-Peng Zhu, Yang Dong, Chun-Lin Zhang
Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index. Clinical and translational medicine 14 (2) (2024)
Maja Jankovic, William Wl Poon, Cristobal Gonzales-Losada, Gabriela Galicia Vazquez, Bahram Sharif-Askari, Yi Ding, Constance Craplet-Desombre, Alexandru Ilie, Jiantao Shi, Yongjie Wang, Ashok Kumar Jayavelu, Alexandre Orthwein, Francois Emile Mercier
The E3 ubiquitin ligase Herc1 modulates the response to nucleoside analogs in acute myeloid leukemia. Blood advances (2024)
Yongjie Wang, Xiaolong Ma, Enjie Xu, Zhen Huang, Chen Yang, Kun-Peng Zhu, Yang Dong, Chun-Lin Zhang
Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index. Clinical and translational medicine 14 (2) (2024)
Yongjie Wang, Xiaolong Ma, Enjie Xu, Zhen Huang, Chen Yang, Kun-Peng Zhu, Yang Dong, Chun-Lin Zhang
Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index. Clinical and translational medicine 14 (2) (2024)
Hanjun Li, Xiuguo Han, Shengbing Yang, Yongjie Wang, Yang Dong, Ting-Ting Tang
FOXP1 drives osteosarcoma development by repressing P21 and RB transcription downstream of P53. Oncogene 40 (15) (2021)